Johnson & Johnson says it will delay European COVID-19 vaccine rollout

Johnson & Johnson says it will delay the rollout of its COVID-19 vaccine in Europe after US authorities moved to suspend the use of the shot due to health concerns.

The US Food and Drug Administration and the Centers for Disease Control moved to “pause” the one-shot COVID-19 inoculation over six reported cases of a rare type of blood clot in the United States.

“We have made the decision to proactively delay the rollout of our vaccine in Europe,” J&J says, adding that it is reviewing the cases with European health authorities.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.